Healthcare & Life Sciences
Aeglea BioTherapeutics
United States
About
Aeglea BioTherapeutics develops engineered human enzymes as novel therapies for rare genetic and metabolic diseases.
Explore Aeglea BioTherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.